The FDA has approved the first oral drug for the treatment of people with relapse-remitting multiple sclerosis (MS). The new drug is called Gilenya and is a pill which is taken once a day. Current drugs are given as injections or infusions and have to be done on either a daily, weekly, or monthly basis. “Gilenya […]
